These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17009872)

  • 21. The current status of gene therapy in autologous transplantation.
    Becker PS
    Acta Haematol; 2005; 114(4):188-97. PubMed ID: 16269858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk potential of the chromosomal insertion of foreign DNA.
    Kurth R
    Ann N Y Acad Sci; 1995 Nov; 772():140-51. PubMed ID: 8546386
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector.
    Evans-Galea MV; Wielgosz MM; Hanawa H; Srivastava DK; Nienhuis AW
    Mol Ther; 2007 Apr; 15(4):801-9. PubMed ID: 17299406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ten years of gene therapy: thoughts and perspectives].
    Cavazzana-Calvo M; Hacein-Bey-Abina S; Fischer A
    Med Sci (Paris); 2010 Feb; 26(2):115-8. PubMed ID: 20188032
    [No Abstract]   [Full Text] [Related]  

  • 25. American Society of Gene Therapy--tenth annual meeting.
    Romano G; Giordano A
    IDrugs; 2007 Aug; 10(8):534-7. PubMed ID: 17665326
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent progress in gene therapy for inherited diseases.
    Wolfe JH
    Curr Opin Pediatr; 1994 Apr; 6(2):213-8. PubMed ID: 8032403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis.
    Biasco L; Rothe M; Schott JW; Schambach A
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):737-752. PubMed ID: 28895844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal stem cells as targets for gene transfer.
    Watt FM
    Hum Gene Ther; 2000 Nov; 11(16):2261-6. PubMed ID: 11084684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning.
    Schwarzer A; Talbot SR; Selich A; Morgan M; Schott JW; Dittrich-Breiholz O; Bastone AL; Weigel B; Ha TC; Dziadek V; Gijsbers R; Thrasher AJ; Staal FJT; Gaspar HB; Modlich U; Schambach A; Rothe M
    Mol Ther; 2021 Dec; 29(12):3383-3397. PubMed ID: 34174440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy: myth or reality? Report of a conference.
    Winship PR
    J R Coll Physicians Lond; 1990 Jul; 24(3):228-32. PubMed ID: 2213679
    [No Abstract]   [Full Text] [Related]  

  • 31. In utero gene therapy: prospect and future.
    Chauhan DP; Srivastava AS; Moustafa ME; Shenouda S; Carrier E
    Curr Pharm Des; 2004; 10(29):3663-72. PubMed ID: 15579062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospects for gene therapy now and in the future.
    Akhurst RJ
    J Inherit Metab Dis; 1989; 12 Suppl 1():191-201. PubMed ID: 2509805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene therapy: current status and promise].
    Kaneda Y
    Nihon Yakurigaku Zasshi; 2001 Apr; 117(4):299-306. PubMed ID: 11338380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Utero Gene Therapy Consensus Statement from the IFeTIS.
    Almeida-Porada G; Waddington SN; Chan JKY; Peranteau WH; MacKenzie T; Porada CD
    Mol Ther; 2019 Apr; 27(4):705-707. PubMed ID: 30837116
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic correction of hereditary disease.
    Johnson MP; Drugan A; Miller OJ; Evans MI
    Fetal Ther; 1989; 4 Suppl 1():28-39. PubMed ID: 2577303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety issues related to retroviral-mediated gene transfer in humans.
    Cornetta K; Morgan RA; Anderson WF
    Hum Gene Ther; 1991; 2(1):5-14. PubMed ID: 1863639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene medicine : a new field of molecular medicine.
    Kim CK; Haider KH; Lim SJ
    Arch Pharm Res; 2001 Feb; 24(1):1-15. PubMed ID: 11235805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article.
    Klapwijk JC; Del Rio Espinola A; Libertini S; Collin P; Fellows MD; Jobling S; Lynch AM; Martus H; Vickers C; Zeller A; Biasco L; Brugman MH; Bushmann FD; Cathomen T; Ertl HCJ; Gabriel R; Gao G; Jadlowsky JK; Kimber I; Lanz TA; Levine BL; Micklethwaite KP; Onodera M; Pizzurro DM; Reed S; Rothe M; Sabatino DE; Salk JJ; Schambach A; Themis M; Yuan J
    Hum Gene Ther; 2024 Aug; 35(15-16):527-542. PubMed ID: 39049734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy, concepts, current trials and future directions.
    Tolstoshev P
    Annu Rev Pharmacol Toxicol; 1993; 33():573-96. PubMed ID: 8494352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.
    Métais JY; Dunbar CE
    Mol Ther; 2008 Mar; 16(3):439-49. PubMed ID: 18227842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.